Title: BILLAS PASSED BY THE HOUSE H.46
Official Title: BILLAS PASSED BY THE HOUSE H.46
Number of Sections: 2
Source: versions - As Passed By the House (Official)
Media Type: application/pdf
Strikethrough Detection: 10 sections found

================================================================================

Section 1:
2025 Page 1 of 10
1 H.46
2 Introduced by Representatives Donahue of Northfield, Noyes of Wolcott, and
3 Stone of Burlington
4 Referred to Committee on
5 Date:
6 Subject: Health; rare diseases; advisory council
7 Statement of purpose of bill as introduced: This bill proposes to establish the
8 Rare Disease Advisory Council.
9 An act relating to the Rare Disease Advisory Council
10 It is hereby enacted by the General Assembly of the State of Vermont:
11 Sec. 1. 18 V.S.A. chapter 19 is added to read:
12 CHAPTER 19. RARE DISEASES
13 § 981. RARE DISEASE ADVISORY COUNCIL
14 (a) Creation. There is created the Rare Disease Advisory Council within
15 the Department of Health to provide guidance and recommendations to the
16 public, General Assembly, and other government agencies and departments, as
17 necessary, regarding the needs of individuals living with rare diseases in
18 Vermont.
19 (b) Membership.
BILLAS PASSED BY THE HOUSE H.46
2025 Page 2 of 10
1 (1) The Advisory Council shall be composed of the following members,
2 with members potentially fulfilling multiple roles if the member meets
3 qualifications of more than one subdivision:
4 (A) the Commissioner of Health or designee;
5 (B) the Commissioner of Vermont Health Access or designee;
6 (C) the Commissioner of Financial Regulation or designee;
7 (D) the Director of the Office of Racial Equity or designee;
8 (E) two individuals living with a rare disease, one appointed by the
9 Speaker of the House and one appointed by the Senate Committee on
10 Committees;
11 (F) a representative of an academic research institution in the State
12 that receives grant funding for rare disease research, appointed by the Speaker
13 of the House;
14 (G) a caregiver of a person living with a rare disease, appointed by
15 the Senate Committee on Committees;
16 (H) a physician practicing in Vermont with experience treating a rare
17 disease, appointed by the Vermont Medical Society;
18 (I) a nurse practicing in Vermont with experience treating a rare
19 disease, appointed by the Vermont chapter of the American Nurses
20 Association;
BILLAS PASSED BY THE HOUSE H.46
2025 Page 3 of 10
1 (J) a geneticist or genetic counselor, appointed by the Senate
2 Committee on Committees;
3 (K) a representative of health insurance companies serving
4 Vermonters, appointed jointly by Blue Cross Blue Shield of Vermont and MVP
5 Health Care;
6 (L) a representative of the biopharma industry doing business in
7 Vermont, appointed by the Speaker of the House; and
8 (M) a representative of a rare disease patient organization
9 operating in Vermont, appointed by the Governor.
10 (2) In event there is an even number of members on the
11 Advisory Council after the appointments are made pursuant to
12 subdivision (1) of this section, the Governor shall appoint one
13 additional member, provided the member aligns with the Advisory
14 Council’s purpose and prioritizes representation of patients and
15 caregivers.
16 (c) Powers and duties. The Advisory Council shall conduct the following
17 activities for the benefit of individuals impacted by rare diseases in Vermont:
18 (1) convene public hearings, make inquiries, and solicit comments from
19 the general public to assist the Advisory Council with an initial needs
20 assessment of individuals with a rare disease in Vermont and the needs of their
21 caregivers and providers;
BILLAS PASSED BY THE HOUSE H.46
2025 Page 4 of 10
1 (2) provide testimony and comments on pending legislation and rules
2 that impact Vermont’s rare disease community before the General Assembly
3 and other State agencies;
4 (3) consult with experts on rare diseases to develop policy
5 recommendations that:
6 (A) improve patient access to and quality of services provided by
7 rare disease specialists;
8 (B) advance affordable and comprehensive health care coverage;
9 (C) provide relevant diagnostic services and improve programs such
10 as the State’s newborn screening program; and
11 (D) ensure timely treatment and other needed services;
12 (4) publish a list of existing, publicly accessible resources on research,
13 diagnosis, and treatment, including education resources for health care
14 providers, relating to rare diseases on the Advisory Council’s website;
15 (5) review the Department of Health’s January 2025 presentation
16 describing the public health impact of rare diseases in Vermont and the
17 Department’s role in addressing rare diseases statewide as required by 2024
18 Acts and Resolved No. 164, Sec. 2; and
19 (6) any other priorities identified by the Department of Health or a
20 majority of the Advisory Council.
BILLAS PASSED BY THE HOUSE H.46
2025 Page 5 of 10
1 (d) Assistance. The Advisory Council shall have the administrative,
2 technical, and legal assistance of the Department of Health.
3 (e) Report. Annually, on or before December 15, the Advisory Council
4 shall submit a written report to the House Committees on Health Care and on
5 Human Services and to the Senate Committee on Health and Welfare with its
6 findings and any recommendations for legislative action, including:
7 (1) a description of the activities and progress of the Advisory Council
8 during the previous year; and
9 (2) an update on the status of the Advisory Council’s funding needs.
10 (f) Meetings.
11 (1) The Commissioner of Health or designee shall call the first meeting
12 of the Advisory Council.
13 (2) The Commissioner of Health or designee shall serve as the chair.
14 (3) During the first year of enactment, the Advisory Council shall meet
15 on at least a monthly basis and thereafter by the call of the Chair. Meetings
16 may be held in person or remotely on an electronic platform as determined by
17 the Chair.
18 (4) A majority of the membership shall constitute a quorum.
19 (5) The Advisory Council shall maintain a web page on the Department
20 of Health’s website containing notices of upcoming meetings, meeting
21 minutes, public comments, and previous annual reports.
BILLAS PASSED BY THE HOUSE H.46
2025 Page 6 of 10
1 (g) Compensation and reimbursement. The members of the Advisory
2 Council not otherwise compensated for their participation shall be entitled to
3 per diem compensation and reimbursement of expenses as permitted under
4 32 V.S.A. § 1010 for not more than 12 meetings annually. These payments
5 shall be made from monies appropriated to the Department of Health.
6 Sec. 2. EFFECTIVE DATE
7 This act shall take effect on July 1, 2025.
Sec. 1. FINDINGS
The General Assembly finds that:
(1) lack of awareness contributes to common and harmful obstacles that
rare disease patients face, such as delays in diagnosis, misdiagnosis, lack of
treatment options, high out-of-pocket costs, and limited access to medical
specialists; and
(2) with the support of the National Organization for Rare Disorders,
various patient organizations, and stakeholders in the rare disease community,
rare disease advisory councils are enabling states to strategically identify and
address barriers that prevent individuals living with rare disease from
accessing adequate and effective treatment and care for their condition.
Sec. 2. 18 V.S.A. chapter 19 is added to read:
CHAPTER 19. RARE DISEASES

Section 2:
§ 981. RARE DISEASE ADVISORY COUNCIL
BILLAS PASSED BY THE HOUSE H.46
2025 Page 7 of 10
(a) Creation. There is created the Rare Disease Advisory Council within
the Department of Health to provide guidance and recommendations to the
public, General Assembly, and other government agencies and departments, as
necessary, regarding the needs of individuals living with rare diseases in
Vermont.
(b) Membership.
(1) The Advisory Council shall be composed of the following members:
(A) two individuals living with a rare disease, at least one of whom is
an older Vermonter, one appointed by the Speaker of the House and one
appointed by the Senate Committee on Committees;
(B) a parent or guardian of a person living with a rare disease,
appointed by the Senate Committee on Committees;
(C) the Commissioner of Health or designee;
(D) the Commissioner of Disabilities, Aging, and Independent Living
or designee;
(E) a representative of the Heath Equity Advisory Commission
established pursuant to section 252 of this title;
(F) an academic researcher who conducts rare disease research,
appointed by the Speaker of the House;
(G) a physician practicing in Vermont with experience treating a rare
disease, appointed by the Vermont Medical Society;
BILLAS PASSED BY THE HOUSE H.46
2025 Page 8 of 10
(H) a nurse practicing in Vermont with experience treating a rare
disease, appointed by the Vermont chapter of the American Nurses
Association;
(I) a pharmacist practicing in Vermont, appointed by the Senate
Committee on Committees; and
(J) a geneticist or genetic counselor, appointed by the Senate
Committee on Committees.
(2) The Advisory Council shall collaborate with any other relevant
stakeholders it deems appropriate, including the National Organization
for Rare Disorders.
(c) Powers and duties. The Advisory Council may conduct the following
activities for the benefit of individuals impacted by rare diseases in Vermont:
(1) convene public hearings and solicit comments from individuals
impacted by rare diseases to assist the Advisory Council with creating a needs
assessment identifying gaps in services for individuals with a rare disease in
Vermont and the needs of their caregivers and providers;
(2) provide testimony and comments on pending legislation and rules
that impact Vermont’s rare disease community before the General Assembly
and other State agencies;
(3) consult with experts on rare diseases to develop policy
recommendations that:
BILLAS PASSED BY THE HOUSE H.46
2025 Page 9 of 10
(A) identify conditions to recommend to the Newborn Screening
Advisory Committee as part of the Vermont Newborn Screening Program; and
(B) support timely patient access to diagnostic services and treatment
and enhance quality of services provided by rare disease specialists;
(4) maintain a web page on the Department of Health’s website to serve
as a resource for individuals with a rare disease that contains notices of
upcoming meetings, meeting minutes, public comments, and previous annual
reports; and
(5) any other activities identified by a majority of the Advisory Council.
(d) Assistance. The Advisory Council shall have the administrative,
technical, and legal assistance of the Department of Health.
(e) Report. As needed, the Advisory Council may submit any
recommendations for legislative action to the House Committees on Health
Care and on Human Services and to the Senate Committee on Health and
Welfare.
(f) Meetings.
(1) The Commissioner of Health or designee shall call the first meeting
of the Advisory Council.
(2) Annually, the Advisory Council shall elect a member to serve as the
Chair.
BILLAS PASSED BY THE HOUSE H.46
2025 Page 10 of 10
(3) The Advisory Council shall meet quarterly. Meetings may be held in
person or remotely on an electronic platform as determined by the Chair.
(4) A majority of the membership shall constitute a quorum.
(g) Compensation and reimbursement. The members of the Advisory
Council not otherwise compensated for their participation shall be entitled to
per diem compensation and reimbursement of expenses as permitted under
32 V.S.A. § 1010 for not more than four meetings annually.
Sec. 3. EFFECTIVE DATE
This act shall take effect on July 1, 2026.
[DELETED: LASPDBYTEHEH5Pe1of1HIdbyRsDeofN,NsofW,aSeofBRdtoCeoDS:H;red;aycStofpeofblasi:TsblpstoehtReDeAyCAnatrgtoteReDeAyC0ItishyedbyteGlAyofteSeofV1S.1.18V.cr19isadtor2CR1.RED3§.REDEAYC4()C.TeiscdteReDeAyClw5teDtofHhtopegeadrstot6p,GlA,adorgtasadd,a7n,rgtensofislgwhredsi8V9()M]
[DELETED: LASPDBYTEHEH5Pe2of1()TeAyClslbecdoftefgmwhmspyfgmersiftemrmqsofmetnoes()teCrofHhord()teCrofVtHhAsord()teCrofFlRnord()teDrofteOeofRlEyord()toislgwhared,oeadbytSrofteHeadoeadbyteSeCeo0C1()areofanacrhininteS2ttrsgtfgfrreder,adbyteS3ofteH4()acrofapnlgwhared,adb5teSeCeonC6()apnpginVtwheetgar7d,adbyteVtMlS8()anepginVtwheetgar9d,adbyteVtcrofteAnN0A]
[DELETED: LASPDBYTEHEH5Pe3of1()agtorgcc,adbyteSCeonC()areofhhiecssV,adjybyBeCsBeSdofVtadMHhC()areoftebaiydgbsiV,adbyteSrofteH;a()arfaedeptooginV,adbyteG0()Inetteisanennrofmsont1AyClarteasaemeptt2sn()oftss,teGrslato3alm,pdtemraswhteA4Cspeadpsrnofpsa5c6()Psadd.TeAyClslcttef7asfrtebtofisidbyredsinV8()cepch,mei,adstcsf9teglpctoatteAyClwhaniln0atofiswharedeinVtadtensoft1csadp]
[DELETED: LASPDBYTEHEH5Pe4of1()petyadcsonpglnadrttitVsredecybeteGlAadorSea()ctwhesonredstodpprst()ieptastoadqyofsspdbredes()aeaeadcehhcec()pertdcssadiepss0asteSsnnsgp;a1()eetyttadornds2()phaltofe,pyaersonr3d,adt,igenrsfrhhc4p,rgtoredsonteAyCsw5()rwteDtofHsJy25p6dgtepchhitofredsinVtadt7Dsreinagredsseasrdby28AsadRdN.1,S.2;a9()ayorpsidbyteDtofHhor0myofteAyC]
[DELETED: LASPDBYTEHEH5Pe5of1()A.TeAyClslheteat,adllaeofteDtofH()R.A,onorbeDr1,teAyCslstawnrttoteHeCsonHhCeadoHnSsadtoteSeCeonHhadWewhifsadayrsfrlea,i()adnofteasadpsofteAyCdgtepsy;a()anueontessofteAyCsfgn0()M1()TeCrofHhordeslclteftm2ofteAyC3()TeCrofHhordeslseastec4()Dgteftyrofe,teAyClslm5onatltamybsadtrbyteclofteC.M6mybehdinpnorryonanecpmasddb7teC8()Amyoftempslceaq9()TeAyClslmnawbpeonteD0ofHswecgnsofugm,m1m,pcc,adpsalr]
[DELETED: LASPDBYTEHEH5Pe6of1()Cnadr.TemsofteAClntoecdfrtrpnslbeedtprdmcnadrtofesaspdu3.§0frntmetn12msa.TepslbemefmmsadtoteDtofHS.2.EEDTsatslteetonJy1,2.1.FeGlAyfst)lkofascstocnadhlostedepsf,shasdsind,m,lkoto,hhotc,adldastom;a)whtestofteNlOnfrReDspto,adssinteredecedeaycsaeegsstosyiyasbsttptislgwhredefgaeadeettadcefrtrc.2.18V.cr19isadtorR1.RED.REDEAYC]
[DELETED: LASPDBYTEHEH5Pe7of1)C.TeiscdteReDeAyClweDtofHhtopegeadrstot,GlA,adorgtasadd,a,rgtensofislgwhredsi)M)TeAyClslbecdoftefgm)toislgwhared,atltoeofwminorV,oeadbyteSrofteHeadodbyteSeCeonC)aptorgnofapnlgwhareddbyteSeCeonC)teCrofHhord)teCrofD,A,adItLrd)areofteHhEyAyCdpttosn22oftst)anacrrwocsrederdbyteSrofteH)apnpginVtwheetgar,adbyteVtMlS]
[DELETED: LASPDBYTEHEH5Pe8of1)anepginVtwheetgar,adbyteVtcrofteAnN)aptpginV,adbyteSeonC;a)agtorgcc,adbyteSeonC)TeAyClslcewhayorrsitdsa,igteNlOrReD)Psadd.TeAyClmycttefsfrtebtofisidbyredsinV)cepchsadstcsfmidbyredstoatteAyClwhcgantiggsinssfriswharedeitadtensoftrcsadp)petyadcsonpglnadrtitVsredecybeteGlAdorSea)ctwhesonredstodppst]
[DELETED: LASPDBYTEHEH5Pe9of1)iycstordtoteNnSyCeasptofteVtNnSgP;a)sttyptastodcssadtdeeqyofsspdbyredes)mnawbpeonteDtofHswetossarefriswharedettcsnsogm,mgm,pcc,adpsa;a)ayorasidbyamyofteAyC)A.TeAyClslhetea,adllaeofteDtofH)R.Asn,teAyClmystasfrleantoteHeCsonHeadonHnSsadtoteSeCeonHha)M)TeCrofHhordeslclteftmfteAyC)A,teAyClsletamrtoseast]
[DELETED: LASPDBYTEHEH5Pe10of1)TeAyClslmtq.MsmybehdinorryonanecpmasddbyteC)Amyoftempslceaq)Cnadr.TemsofteAlntoecdfrtrpnslbeedtrdmcnadrtofesaspdu.§0frntmetnfrmsa.3.EEDsatslteetonJy1,2]


================================================================================

Raw Text:
BILLAS PASSED BY THE HOUSE H.46
2025 Page 1 of 10
1 H.46
2 Introduced by Representatives Donahue of Northfield, Noyes of Wolcott, and
3 Stone of Burlington
4 Referred to Committee on
5 Date:
6 Subject: Health; rare diseases; advisory council
7 Statement of purpose of bill as introduced: This bill proposes to establish the
8 Rare Disease Advisory Council.
9 An act relating to the Rare Disease Advisory Council
10 It is hereby enacted by the General Assembly of the State of Vermont:
11 Sec. 1. 18 V.S.A. chapter 19 is added to read:
12 CHAPTER 19. RARE DISEASES
13 § 981. RARE DISEASE ADVISORY COUNCIL
14 (a) Creation. There is created the Rare Disease Advisory Council within
15 the Department of Health to provide guidance and recommendations to the
16 public, General Assembly, and other government agencies and departments, as
17 necessary, regarding the needs of individuals living with rare diseases in
18 Vermont.
19 (b) Membership.

BILLAS PASSED BY THE HOUSE H.46
2025 Page 2 of 10
1 (1) The Advisory Council shall be composed of the following members,
2 with members potentially fulfilling multiple roles if the member meets
3 qualifications of more than one subdivision:
4 (A) the Commissioner of Health or designee;
5 (B) the Commissioner of Vermont Health Access or designee;
6 (C) the Commissioner of Financial Regulation or designee;
7 (D) the Director of the Office of Racial Equity or designee;
8 (E) two individuals living with a rare disease, one appointed by the
9 Speaker of the House and one appointed by the Senate Committee on
10 Committees;
11 (F) a representative of an academic research institution in the State
12 that receives grant funding for rare disease research, appointed by the Speaker
13 of the House;
14 (G) a caregiver of a person living with a rare disease, appointed by
15 the Senate Committee on Committees;
16 (H) a physician practicing in Vermont with experience treating a rare
17 disease, appointed by the Vermont Medical Society;
18 (I) a nurse practicing in Vermont with experience treating a rare
19 disease, appointed by the Vermont chapter of the American Nurses
20 Association;

BILLAS PASSED BY THE HOUSE H.46
2025 Page 3 of 10
1 (J) a geneticist or genetic counselor, appointed by the Senate
2 Committee on Committees;
3 (K) a representative of health insurance companies serving
4 Vermonters, appointed jointly by Blue Cross Blue Shield of Vermont and MVP
5 Health Care;
6 (L) a representative of the biopharma industry doing business in
7 Vermont, appointed by the Speaker of the House; and
8 (M) a representative of a rare disease patient organization
9 operating in Vermont, appointed by the Governor.
10 (2) In event there is an even number of members on the
11 Advisory Council after the appointments are made pursuant to
12 subdivision (1) of this section, the Governor shall appoint one
13 additional member, provided the member aligns with the Advisory
14 Council’s purpose and prioritizes representation of patients and
15 caregivers.
16 (c) Powers and duties. The Advisory Council shall conduct the following
17 activities for the benefit of individuals impacted by rare diseases in Vermont:
18 (1) convene public hearings, make inquiries, and solicit comments from
19 the general public to assist the Advisory Council with an initial needs
20 assessment of individuals with a rare disease in Vermont and the needs of their
21 caregivers and providers;

BILLAS PASSED BY THE HOUSE H.46
2025 Page 4 of 10
1 (2) provide testimony and comments on pending legislation and rules
2 that impact Vermont’s rare disease community before the General Assembly
3 and other State agencies;
4 (3) consult with experts on rare diseases to develop policy
5 recommendations that:
6 (A) improve patient access to and quality of services provided by
7 rare disease specialists;
8 (B) advance affordable and comprehensive health care coverage;
9 (C) provide relevant diagnostic services and improve programs such
10 as the State’s newborn screening program; and
11 (D) ensure timely treatment and other needed services;
12 (4) publish a list of existing, publicly accessible resources on research,
13 diagnosis, and treatment, including education resources for health care
14 providers, relating to rare diseases on the Advisory Council’s website;
15 (5) review the Department of Health’s January 2025 presentation
16 describing the public health impact of rare diseases in Vermont and the
17 Department’s role in addressing rare diseases statewide as required by 2024
18 Acts and Resolved No. 164, Sec. 2; and
19 (6) any other priorities identified by the Department of Health or a
20 majority of the Advisory Council.

BILLAS PASSED BY THE HOUSE H.46
2025 Page 5 of 10
1 (d) Assistance. The Advisory Council shall have the administrative,
2 technical, and legal assistance of the Department of Health.
3 (e) Report. Annually, on or before December 15, the Advisory Council
4 shall submit a written report to the House Committees on Health Care and on
5 Human Services and to the Senate Committee on Health and Welfare with its
6 findings and any recommendations for legislative action, including:
7 (1) a description of the activities and progress of the Advisory Council
8 during the previous year; and
9 (2) an update on the status of the Advisory Council’s funding needs.
10 (f) Meetings.
11 (1) The Commissioner of Health or designee shall call the first meeting
12 of the Advisory Council.
13 (2) The Commissioner of Health or designee shall serve as the chair.
14 (3) During the first year of enactment, the Advisory Council shall meet
15 on at least a monthly basis and thereafter by the call of the Chair. Meetings
16 may be held in person or remotely on an electronic platform as determined by
17 the Chair.
18 (4) A majority of the membership shall constitute a quorum.
19 (5) The Advisory Council shall maintain a web page on the Department
20 of Health’s website containing notices of upcoming meetings, meeting
21 minutes, public comments, and previous annual reports.

BILLAS PASSED BY THE HOUSE H.46
2025 Page 6 of 10
1 (g) Compensation and reimbursement. The members of the Advisory
2 Council not otherwise compensated for their participation shall be entitled to
3 per diem compensation and reimbursement of expenses as permitted under
4 32 V.S.A. § 1010 for not more than 12 meetings annually. These payments
5 shall be made from monies appropriated to the Department of Health.
6 Sec. 2. EFFECTIVE DATE
7 This act shall take effect on July 1, 2025.
Sec. 1. FINDINGS
The General Assembly finds that:
(1) lack of awareness contributes to common and harmful obstacles that
rare disease patients face, such as delays in diagnosis, misdiagnosis, lack of
treatment options, high out-of-pocket costs, and limited access to medical
specialists; and
(2) with the support of the National Organization for Rare Disorders,
various patient organizations, and stakeholders in the rare disease community,
rare disease advisory councils are enabling states to strategically identify and
address barriers that prevent individuals living with rare disease from
accessing adequate and effective treatment and care for their condition.
Sec. 2. 18 V.S.A. chapter 19 is added to read:
CHAPTER 19. RARE DISEASES
§ 981. RARE DISEASE ADVISORY COUNCIL

BILLAS PASSED BY THE HOUSE H.46
2025 Page 7 of 10
(a) Creation. There is created the Rare Disease Advisory Council within
the Department of Health to provide guidance and recommendations to the
public, General Assembly, and other government agencies and departments, as
necessary, regarding the needs of individuals living with rare diseases in
Vermont.
(b) Membership.
(1) The Advisory Council shall be composed of the following members:
(A) two individuals living with a rare disease, at least one of whom is
an older Vermonter, one appointed by the Speaker of the House and one
appointed by the Senate Committee on Committees;
(B) a parent or guardian of a person living with a rare disease,
appointed by the Senate Committee on Committees;
(C) the Commissioner of Health or designee;
(D) the Commissioner of Disabilities, Aging, and Independent Living
or designee;
(E) a representative of the Heath Equity Advisory Commission
established pursuant to section 252 of this title;
(F) an academic researcher who conducts rare disease research,
appointed by the Speaker of the House;
(G) a physician practicing in Vermont with experience treating a rare
disease, appointed by the Vermont Medical Society;

BILLAS PASSED BY THE HOUSE H.46
2025 Page 8 of 10
(H) a nurse practicing in Vermont with experience treating a rare
disease, appointed by the Vermont chapter of the American Nurses
Association;
(I) a pharmacist practicing in Vermont, appointed by the Senate
Committee on Committees; and
(J) a geneticist or genetic counselor, appointed by the Senate
Committee on Committees.
(2) The Advisory Council shall collaborate with any other relevant
stakeholders it deems appropriate, including the National Organization
for Rare Disorders.
(c) Powers and duties. The Advisory Council may conduct the following
activities for the benefit of individuals impacted by rare diseases in Vermont:
(1) convene public hearings and solicit comments from individuals
impacted by rare diseases to assist the Advisory Council with creating a needs
assessment identifying gaps in services for individuals with a rare disease in
Vermont and the needs of their caregivers and providers;
(2) provide testimony and comments on pending legislation and rules
that impact Vermont’s rare disease community before the General Assembly
and other State agencies;
(3) consult with experts on rare diseases to develop policy
recommendations that:

BILLAS PASSED BY THE HOUSE H.46
2025 Page 9 of 10
(A) identify conditions to recommend to the Newborn Screening
Advisory Committee as part of the Vermont Newborn Screening Program; and
(B) support timely patient access to diagnostic services and treatment
and enhance quality of services provided by rare disease specialists;
(4) maintain a web page on the Department of Health’s website to serve
as a resource for individuals with a rare disease that contains notices of
upcoming meetings, meeting minutes, public comments, and previous annual
reports; and
(5) any other activities identified by a majority of the Advisory Council.
(d) Assistance. The Advisory Council shall have the administrative,
technical, and legal assistance of the Department of Health.
(e) Report. As needed, the Advisory Council may submit any
recommendations for legislative action to the House Committees on Health
Care and on Human Services and to the Senate Committee on Health and
Welfare.
(f) Meetings.
(1) The Commissioner of Health or designee shall call the first meeting
of the Advisory Council.
(2) Annually, the Advisory Council shall elect a member to serve as the
Chair.

BILLAS PASSED BY THE HOUSE H.46
2025 Page 10 of 10
(3) The Advisory Council shall meet quarterly. Meetings may be held in
person or remotely on an electronic platform as determined by the Chair.
(4) A majority of the membership shall constitute a quorum.
(g) Compensation and reimbursement. The members of the Advisory
Council not otherwise compensated for their participation shall be entitled to
per diem compensation and reimbursement of expenses as permitted under
32 V.S.A. § 1010 for not more than four meetings annually.
Sec. 3. EFFECTIVE DATE
This act shall take effect on July 1, 2026.

[DELETED: LASPDBYTEHEH5Pe1of1HIdbyRsDeofN,NsofW,aSeofBRdtoCeoDS:H;red;aycStofpeofblasi:TsblpstoehtReDeAyCAnatrgtoteReDeAyC0ItishyedbyteGlAyofteSeofV1S.1.18V.cr19isadtor2CR1.RED3§.REDEAYC4()C.TeiscdteReDeAyClw5teDtofHhtopegeadrstot6p,GlA,adorgtasadd,a7n,rgtensofislgwhredsi8V9()M]
[DELETED: LASPDBYTEHEH5Pe2of1()TeAyClslbecdoftefgmwhmspyfgmersiftemrmqsofmetnoes()teCrofHhord()teCrofVtHhAsord()teCrofFlRnord()teDrofteOeofRlEyord()toislgwhared,oeadbytSrofteHeadoeadbyteSeCeo0C1()areofanacrhininteS2ttrsgtfgfrreder,adbyteS3ofteH4()acrofapnlgwhared,adb5teSeCeonC6()apnpginVtwheetgar7d,adbyteVtMlS8()anepginVtwheetgar9d,adbyteVtcrofteAnN0A]
[DELETED: LASPDBYTEHEH5Pe3of1()agtorgcc,adbyteSCeonC()areofhhiecssV,adjybyBeCsBeSdofVtadMHhC()areoftebaiydgbsiV,adbyteSrofteH;a()arfaedeptooginV,adbyteG0()Inetteisanennrofmsont1AyClarteasaemeptt2sn()oftss,teGrslato3alm,pdtemraswhteA4Cspeadpsrnofpsa5c6()Psadd.TeAyClslcttef7asfrtebtofisidbyredsinV8()cepch,mei,adstcsf9teglpctoatteAyClwhaniln0atofiswharedeinVtadtensoft1csadp]
[DELETED: LASPDBYTEHEH5Pe4of1()petyadcsonpglnadrttitVsredecybeteGlAadorSea()ctwhesonredstodpprst()ieptastoadqyofsspdbredes()aeaeadcehhcec()pertdcssadiepss0asteSsnnsgp;a1()eetyttadornds2()phaltofe,pyaersonr3d,adt,igenrsfrhhc4p,rgtoredsonteAyCsw5()rwteDtofHsJy25p6dgtepchhitofredsinVtadt7Dsreinagredsseasrdby28AsadRdN.1,S.2;a9()ayorpsidbyteDtofHhor0myofteAyC]
[DELETED: LASPDBYTEHEH5Pe5of1()A.TeAyClslheteat,adllaeofteDtofH()R.A,onorbeDr1,teAyCslstawnrttoteHeCsonHhCeadoHnSsadtoteSeCeonHhadWewhifsadayrsfrlea,i()adnofteasadpsofteAyCdgtepsy;a()anueontessofteAyCsfgn0()M1()TeCrofHhordeslclteftm2ofteAyC3()TeCrofHhordeslseastec4()Dgteftyrofe,teAyClslm5onatltamybsadtrbyteclofteC.M6mybehdinpnorryonanecpmasddb7teC8()Amyoftempslceaq9()TeAyClslmnawbpeonteD0ofHswecgnsofugm,m1m,pcc,adpsalr]
[DELETED: LASPDBYTEHEH5Pe6of1()Cnadr.TemsofteAClntoecdfrtrpnslbeedtprdmcnadrtofesaspdu3.§0frntmetn12msa.TepslbemefmmsadtoteDtofHS.2.EEDTsatslteetonJy1,2.1.FeGlAyfst)lkofascstocnadhlostedepsf,shasdsind,m,lkoto,hhotc,adldastom;a)whtestofteNlOnfrReDspto,adssinteredecedeaycsaeegsstosyiyasbsttptislgwhredefgaeadeettadcefrtrc.2.18V.cr19isadtorR1.RED.REDEAYC]
[DELETED: LASPDBYTEHEH5Pe7of1)C.TeiscdteReDeAyClweDtofHhtopegeadrstot,GlA,adorgtasadd,a,rgtensofislgwhredsi)M)TeAyClslbecdoftefgm)toislgwhared,atltoeofwminorV,oeadbyteSrofteHeadodbyteSeCeonC)aptorgnofapnlgwhareddbyteSeCeonC)teCrofHhord)teCrofD,A,adItLrd)areofteHhEyAyCdpttosn22oftst)anacrrwocsrederdbyteSrofteH)apnpginVtwheetgar,adbyteVtMlS]
[DELETED: LASPDBYTEHEH5Pe8of1)anepginVtwheetgar,adbyteVtcrofteAnN)aptpginV,adbyteSeonC;a)agtorgcc,adbyteSeonC)TeAyClslcewhayorrsitdsa,igteNlOrReD)Psadd.TeAyClmycttefsfrtebtofisidbyredsinV)cepchsadstcsfmidbyredstoatteAyClwhcgantiggsinssfriswharedeitadtensoftrcsadp)petyadcsonpglnadrtitVsredecybeteGlAdorSea)ctwhesonredstodppst]
[DELETED: LASPDBYTEHEH5Pe9of1)iycstordtoteNnSyCeasptofteVtNnSgP;a)sttyptastodcssadtdeeqyofsspdbyredes)mnawbpeonteDtofHswetossarefriswharedettcsnsogm,mgm,pcc,adpsa;a)ayorasidbyamyofteAyC)A.TeAyClslhetea,adllaeofteDtofH)R.Asn,teAyClmystasfrleantoteHeCsonHeadonHnSsadtoteSeCeonHha)M)TeCrofHhordeslclteftmfteAyC)A,teAyClsletamrtoseast]
[DELETED: LASPDBYTEHEH5Pe10of1)TeAyClslmtq.MsmybehdinorryonanecpmasddbyteC)Amyoftempslceaq)Cnadr.TemsofteAlntoecdfrtrpnslbeedtrdmcnadrtofesaspdu.§0frntmetnfrmsa.3.EEDsatslteetonJy1,2]